Closing a perforated duodenal ulcer with a stent was feasible and did not appear to differ from surgical closure in outcomes, a small randomized Swedish study suggested. In the 42-patient study, the ...

Expert Rev Gastroenterol Hepatol. 2012;6(1):105-114. When double-stent placement (duodenal and biliary) is considered, biliary stent placement can be performed either preceding or following duodenal ...

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Cook Medical announced today that its Evolution ® Duodenal Controlled-Release Stent was recently granted 510(k) clearance by the Food & Drug Administration (FDA).

Gastric-outlet obstruction (GOO) refers to mechanical or functional obstruction of the flow of gastric contents into the small intestine. Symptoms of GOO include early satiety, postprandial abdominal ...

Cook Medical has received FDA clearance for its Evolution duodenal controlled-release stent to help patients experiencing issues associated with malignant gastric outlet obstruction, a late-stage ...

A gastrointestinal stent from Cook Medical now has 510 (k) clearance from the U.S. Food and Drug Administration for use in patients suffering GI obstructions caused by cancer. Bloomington, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Using endoscopic ...

One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors—ticagrelor or prasugrel—in people with Type 1 ...